Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2021

Pharma News, 2021

Pacira BioSciences begins commercial production of EXPAREL at Swindon facility
Pacira BioSciences begins commercial production of EXPAREL at Swindon facility
Pacira BioSciences (NASDAQ.
Jaguar Health's Founder and CEO Lisa Conte to Be Honored with Pure Earth Impact Award
Jaguar Health's Founder and CEO Lisa Conte to Be Honored with Pure Earth Impact Award
SAN FRANCISCO, CA / ACCESSWIRE / September 30, 2021 / Jaguar Health, Inc.
Catalyst wins favorable court ruling on orphan drug
Catalyst wins favorable court ruling on orphan drug
Catalyst Pharmaceuticals (NASDAQ.
Top FDA official takes over vaccine office as agency weighs COVID-19 shots for children
Top FDA official takes over vaccine office as agency weighs COVID-19 shots for children
Peter Marks, one of the Food and Drug Administration's top-ranking officials, has taken over the agency's vaccine review office just as the regulator begins considering whether to clear corona...
AstraZeneca to buy rare disease drugmaker Caelum in small dealer
AstraZeneca to buy rare disease drugmaker Caelum in small dealer
AstraZeneca on Wednesday said it will exercise an option to buy the rest of rare disease drugmaker Caelum Biosciences for $150 million, betting on the promise of an experimental medicine to treat ligh...
NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer
NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer
EDINBURGH, United Kingdom, Sept.
Eisai Initiates Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab (BAN2401) for Early Alzheimer's Disease Under the Accelerated Approval Pathway
Eisai Initiates Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab (BAN2401) for Early Alzheimer's Disease Under the Accelerated Approval Pathway
TOKYO and CAMBRIDGE, Mass, September 27, 2021 - Eisai Co.
France's Sanofi halts work on anti-Covid vaccine
France's Sanofi halts work on anti-Covid vaccine
France's pharmaceutical giant Sanofi, which has lagged rivals in producing new generation Covid-19 vaccines, has said it has decided to halt development of an mRNA candidate and focus on another v...
FDA-Approved Alzheimer’s Drug Will Help Spur Innovation Toward Personalized Therapies
FDA-Approved Alzheimer’s Drug Will Help Spur Innovation Toward Personalized Therapies
September marks Alzheimer’s Awareness Month and Dr.
Kids too young for a COVID-19 vaccine? How to keep them safe
Kids too young for a COVID-19 vaccine? How to keep them safe
With the arrival of the fourth wave of COVID-19 in Canada, and vaccines not yet approved for children under 12, what measures can parents take to protect kids who are not yet immunized?Dr.
More effective treatment of Alzheimer's
More effective treatment of Alzheimer's
Developing effective treatment methods for Alzheimer's disease has proved difficult.
A new oral antiviral drug for COVID is being tested in humans
A new oral antiviral drug for COVID is being tested in humans
Despite the effectiveness of vaccines, we still need drugs to treat COVID.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand